New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
19:09 EDTVRNT, MDR, CBST, AMRN, DRTX, ARTX, MDCOOn The Fly: After Hours Movers
HIGHER: Durata Therapeutics (DRTX), up 5.4% after an FDA Committee voted in favor of its Dalvance injection for the treatment of adult patients with acute bacterial skin and skin structure infections caused by certain bacteria... Amarin (AMRN), up 8.8% after announcing a co-promotion agreement with Kowa Pharmaceuticals America for its Vascepa capsules in the U.S... Verint Systems (VRNT), up 10% after reporting earnings that beat expectations and providing a fiscal year outlook that also topped estimates. LOWER: The Medicines Company (MDCO), down 14.3% after Durata and Cubist Pharmaceuticals (CBST) each received positive votes from FDA panels for bacteria treatments that could compete with its Oritavancin. Cubist (CBST), which confirmed the FDA panel vote intraday, saw shares gain $3.05, or 4.35%, to close at $73.15 for the session... Arotech (ARTX), down 12.5% after reporting fiscal year earnings and revenue that disappointed... McDermott (MDR), down 2.8% after filing to sell 10M tangible equity units and, in a separate release, saying that its first quarter results may differ "substantially" from the company's current expectation.
News For DRTX;MDR;MDCO;AMRN;VRNT;ARTX;CBST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 8, 2014
13:12 EDTCBSTMerck paid full price but made good deal for Cubist, says UBS
Subscribe for More Information
12:40 EDTCBSTOn The Fly: Midday Wrap
Subscribe for More Information
12:25 EDTCBST, MDCOAntibiotic makers rise after Merck agrees to buy Cubist
Subscribe for More Information
10:11 EDTCBST, MDCOHigh option volume stocks
Subscribe for More Information
09:20 EDTCBSTOn The Fly: Pre-market Movers
Subscribe for More Information
08:30 EDTCBSTMerck says deals with Cubist includes $250M break-up fee clause
Subscribe for More Information
08:21 EDTCBSTMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
08:11 EDTCBSTCubist volatility elevated into Merck acquiring for $8.4B in cash
Subscribe for More Information
08:08 EDTCBSTMerck says about $9.5B of debt to be issued related to Cubist deal
Subscribe for More Information
07:13 EDTCBSTMerck to host conference call
Subscribe for More Information
07:01 EDTCBSTMerck to acquire Cubist for $102 per share in cash, or $9.5B
Subscribe for More Information
07:00 EDTCBSTMerck to acquire Cubist for $102 per share in cash
Subscribe for More Information
December 7, 2014
16:29 EDTCBSTMerck in discussions to buy Cubist for $7B, Bloomberg reports
Subscribe for More Information
December 4, 2014
08:17 EDTVRNTVerint Systems should be bought on weakness, says Oppenheimer
Subscribe for More Information
December 3, 2014
18:29 EDTVRNTOn The Fly: After Hours Movers
Subscribe for More Information
16:20 EDTVRNTVerint Systems down 5% following Q3 results, guidance
Subscribe for More Information
16:17 EDTVRNTVerint Systems sees FY16 adjusted EPS $3.65-$3.85, consensus $3.75
Sees FY16 revenue $1.225B-$1.275B, consensus $1.26B.
16:15 EDTVRNTVerint Systems sees FY15 adjusted EPS $3.35-$3.50, consensus $3.42
Subscribe for More Information
16:12 EDTVRNTVerint Systems reports Q3 adjusted EPS 84c, consensus 75c
Reports Q3 adjusted revenue $288.5M, consensus $286.58M.
15:25 EDTVRNTNotable companies reporting after market close
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use